Trends in treatment and outcomes for acute myocardial infarction: 1975–1995
The American Journal of MedicinePublished 1 February 2001
Paul A. Heidenreich, Mark McClellan
Citations168
SJR quartileQ1
SJR score1.00
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The primary reason for the decrease in early mortality from myocardial infarction during the last 20 years appears to be increased use of effective treatments.
Abstract
The primary reason for the decrease in early mortality from myocardial infarction during the last 20 years appears to be increased use of effective treatments.
Keywords
Medicine
PubMedRandomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
2,873 Citations1988R B Sleight, Peter Sleight +4 more
The LancetISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
1,817 Citations1995
58,050 patients entering hospitals up to 24 h after the onset of suspected acute myocardial infarction with no clear contraindications to the study treatments were randomised in a "2 x 2 x 2 factorial" study, reassuring a bout the safety of using nitrates early in acute MI.
The LancetInvasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
1,305 Citations1999
The early invasive approach should be the preferred strategy in most patients with unstable coronary-artery disease who have signs of ischaemia on electrocardiography or raised biochemical markers of myocardial damage.
New England Journal of MedicineCumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
1,141 Citations1992Joseph Lau, Elliott M. Antman +4 more
Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.
New England Journal of MedicineComparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1,019 Citations1989The TIMI Study Group*
The ejection fraction and the incidence of death in the two groups were similar during the hospital period and total mortality within the first 6 days and at 42 days was also similar; the latter comparison was considered statistically significant according to the study criteria.
JAMAComparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial Infarction
1,006 Citations1997Will Weaver
Based on outcomes at hospital discharge or 30 days, primary angioplasty appears to be superior to thrombolytic therapy for treatment of patients with acute myocardial infarction, with the proviso that success rates for angiopLasty are as good as those achieved in these trials.
New England Journal of MedicineTrends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994
831 Citations1998Wayne D. Rosamond, Lloyd E. Chambless +6 more
From 1987 to 1994, there were significant annual decreases in mortality from CHD, and the decline in mortality in the four communities the authors studied may be due largely to improvements in the treatment and secondary prevention of myocardial infarction.
New England Journal of MedicineRecent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors
705 Citations1996Paul G. McGovern, James S. Pankow +5 more
The recent decline in mortality due to CHD in the Minneapolis-St.
JAMAEffects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial Infarction
571 Citations1993Koon Teo
The routine use of class I antiarrhythmic agents after myocardial infarction is associated with increased mortality and the limited data on amiodarone appear promising.
Annals of Internal MedicineThe Decline in Ischemic Heart Disease Mortality Rates
557 Citations1984LEE GOLDMAN, E. FRANCIS COOK
Using reasonable assumptions gathered from the published literature, it is estimated that more than half of the decline in ischemic heart disease mortality between 1968 and 1976 was related to changes in lifestyle, specifically to reductions in serum cholesterol levels and cigarette smoking.
CirculationTreatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.
477 Citations1994William J. Rogers, Laura J. Bowlby +7 more
This large registry experience suggests that management of myocardial infarction in the United States does not yet conform to many of the recent clinical trial recommendations, and thrombolytic therapy is underused, particularly in the elderly and late presenters.
Journal of the American College of CardiologyA two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case–fatality rates of acute myocardial infarction: a community-wide perspective
475 Citations1999Robert J. Goldberg, Jorge Yarzebski +2 more
The results of this population-based study of patients with validated initial AMI provide encouragement for efforts directed at the primary and secondary prevention of AMI given declining incidence and case-fatality rates.
The LancetEFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS
394 Citations1988Salim Yusuf, Stephen MacMahon +2 more
The greatest reduction in mortality occurred during the first week or so of follow-up, with a non-significant further reduction after this early period, suggesting that the early benefit is not rapidly lost.
American Journal of Public HealthForecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.
367 Citations1987Milton C. Weinstein, Pam Coxson +4 more
B baseline projections indicate that the aging of the population, and especially the maturation of the post-World War II baby-boom generation, would increase CHD prevalence and annual incidence, mortality, and costs by about 40-50 per cent by the year 2010.
BMJEffects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.
337 Citations1991Koon Teo, Salim Yusuf +3 more
It is suggested that intravenous magnesium therapy may reduce mortality in patients with acute myocardial infarction, and further large scale trials to confirm or refute these findings are desirable.
Archives of Internal MedicineAdherence to National Guidelines for Drug Treatment of Suspected Acute Myocardial Infarction
287 Citations1996Thomas J. McLaughlin
Evidence-based guidelines for the treat-ment of patients with acute myocardial infarction and the influence of age and gender on highly effective AMI treatments in community hospital settings are examined.
New England Journal of MedicineAdjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical Trials
258 Citations1996Charles H. Hennekens, Christine M. Albert +3 more
The current evidence from published randomized trials and meta-analyses of adjunctive drug therapy with beta-adrenergic antagonists, angiotensin-converting–enzyme inhibitors, nitrates, calcium-channel blockers, antiarrhythmic drugs, and .
Journal of the American College of CardiologyThe Prehospital Electrocardiogram in Acute Myocardial Infarction: Is Its Full Potential Being Realized? fn1fn1The National Registry of Myocardial Infarction 2 is supported by Genentech, Inc., South San Francisco, California.
233 Citations1997John G. Canto, William J. Rogers +4 more
The pre hospital ECG is infrequently utilized for diagnosing myocardial infarction, and among patients with a prehospital ECG, is associated with a longer time from symptom onset to hospital arrival, Despite these shortcomings, the prehospitalECG is a test that may potentially influence the management of patients with acuteMyocardial Infarction.
JAMARecent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study
205 Citations1986Robert J. Goldberg
Medical CareHow Accurate are Hospital Discharge Data for Evaluating Effectiveness of Care?
185 Citations1993Jesse Green, Neil Wintfeld
JAMARecent Changes in Attack and Survival Rates of Acute Myocardial Infarction (1975 Through 1981)
157 Citations1986Robert J. Goldberg
The results of this population-based survey suggest that recently observed declines in the mortality rates of CHD may reflect decreases in out-of-hospital coronary deaths and improving trends in the in-hospital survival of patients with acute myocardial infarction.
Journal of the American College of CardiologyTrends in the use of drag therapies in patients with acute myocardial infarction: 1988 to 1992
122 Citations1994Chris L. Pashos, Sharon‐Lise T. Normand +4 more
Current usage rates of thrombolytic therapy are lower than expected, but trends in usage rates for beta-blockers and calcium channel blockers reflect their increasing and decreasing approval, respectively.
CirculationEvidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979.
88 Citations1982Lee Goldman, Francesca Cook +4 more
It is suggested that improvements in the in-hospital care of acute MI patients are not a major explanation for nationwide mortality trends between 1973 and 1978.
The American Journal of CardiologyVery early thrombolytic therapy in suspected acute myocardial infarction
80 Citations1990
CirculationTrends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota Heart Survey.
78 Citations1992Paul G. McGovern, Aaron R. Folsom +6 more
These results suggest that improvements in survival among hospitalized MI patients contributed to the overall decline in coronary heart disease mortality in the Twin Cities area between 1970 and 1980 but not between 1980 and 1985.
Archives of Internal MedicineRecent Trends in Hospital Mortality of Acute Myocardial Infarction—the Worcester Heart Attack Study
52 Citations1994Jerry H. Gurwitz
While the risk of in-hospital death following acute myocardial infarction has recently declined for patients less than 65 years of age, improvements have not been realized for older age groups.
The American Journal of CardiologyComparison of Short- and Long-Term Prognosis in Patients With Anterior Wall Versus Inferior or Lateral Wall Non-Q-Wave Acute Myocardial Infarction
42 Citations1997Moti Haim, Hanoch Hod +6 more
It is suggested that AMI location is an important prognostic variable for risk stratification of patients with a first non-Q-wave acute myocardial infarction and emerged as a predictor for higher 1-year cardiac event rate.
European Heart JournalLong-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction: Data from the SPRINT Registry
40 Citations1996S. Behar, Moti Haim +12 more
Patients with a first non-Q wave acute myocardial infarction exhibited relatively better in-hospital survival than counterparts with aFirst Q wave infarctions, but the advantage did not persist after discharge.
Archives of Internal MedicineAge-Related Trends (1986-1993) in the Use of Thrombolytic Agents in Patients With Acute Myocardial Infarction
34 Citations1997Harish Chandra
While there have been substantial increases over time in the use of thrombolytic therapy in patients with AMI, most particularly in older individuals, the elderly remain appreciably less likely to receive these agents during hospitalization for AMI.
The American Journal of CardiologyAnticoagulation in myocardial infarction: Modem approach to an old problem
25 Citations1979William H. Frishman, Hillel S. Ribner
Small dose heparin therapy provides an excellent alternative to conventional anticoagulation when there is more than a negligible risk of hemorrhage and is an effective means of preventing the risks of pulmonary and peripheral emboli during the in-patient phase of acute myocardial infarction.
The American Journal of CardiologyImmediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction
25 Citations1993Solomon Behar, Babeth Rabinowitz +13 more
It is indicated that the anatomic location of a Q-wave AMI influences immediate and short-term survival of patients with a first Q-waves acute myocardial infarction.
PubMedUrgent surgical reperfusion in acute evolving myocardial infarction. A randomized controlled study.
21 Citations1988Arvind Koshal, Beanlands Ds +3 more
Urgent surgical reperfusion in acute evolving myocardial infarction is a safe and effective procedure that appears to reduce early and late mortality but does not appear to improve left ventricular function.
CardiologyPrognostic Significance of Infarction Location in Patients with Recurrent Myocardial Infarction
12 Citations2008Ran Kornowski, Uri Goldbourt +6 more
Journal of Clinical EpidemiologyTrends in coded causes of death following definite myocardial infarction and therole of competing risks: The minnesota heart survey (MHS)
11 Citations1994James S. Pankow, Paul G. McGovern +3 more
Trends in long-term death following acute MI may have had a modest impact on reported community-wide coronary heart disease mortality rates, particularly among in-hospital survivors of definite MI.
Clinical CardiologyTherapeutic trends in the management of patients with acute myocardial infarction (1975–1984): the worcester heart attack study
11 Citations1987Robert J. Goldberg, Joel M. Gore +2 more
The results of this population‐based study suggest considerable changes over time in the therapeutic management of patients hospitalized with acute myocardial infarction and of numerous patient demographic and clinical factors associated with their use.
Progress in Cardiovascular DiseasesEarly intravenous β-blocker combined with thrombolytic therapy for acute myocardial infarction: The thrombolysis in myocardial infarction (TIMI-2) trial
8 Citations1993Steven Borzak, Mihai Gheorghiade
The combination of thrombolytic treatment and IV P-blocker treatments individually and in combination may be complementary and potentially reduce mortality as compared with either agent used alone, despite little prospective data support such an approach.